secwatch.observer — SEC 8-K summary
======================================

Issuer:     Skye Bioscience, Inc. (SKYE)
CIK:        0001516551
Form:       8-K
Filed at:   2023-09-07T23:59:59+00:00
Accession:  0001516551-23-000073
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Skye Bioscience announces 1-for-250 reverse stock split effective Sept 8, 2023
------------------------------------------------------------------------------

- Reverse split at 1:250 reduces outstanding shares from ~3.078B to ~12.3M.
- Authorized shares reduced from 5B to 20M; ticker SKYE gets 'D' for 20 trading days.
- No stockholder vote required; fractional shares rounded up to whole shares.
- Effective Sept 8, 2023; new CUSIP 83086J200 for common stock.
- Each holder's percentage ownership unchanged except for rounding adjustments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1516551/000151655123000073/0001516551-23-000073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1516551/000151655123000073/skye-20230906.htm
  HTML page:      https://secwatch.observer/filing/0001516551-23-000073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer